Vinozest 50mg Injection

Vinozest 50mg Injection is an anticancer medicine with Vinorelbine as an active ingredient which is a alkaloid chemotherapy medication. It is prescribed to treat breast cancer and non small cell lung cancer.

This injection acts by blocking the microtubule structure within the cell to control the progression of cancer. This injection should be administered into the vein by a doctor or experienced nurse. Don't self- administer the injection.

• Breast cancer
• Non-small cell lung cancer

Vinozest 50mg Injection   is a strong anticancer medicine that may show certain adverse while manageable impact on the body during the treatment. As these effects resolve on their own without any special medical attention. However, if you ever experience serious or unusual side effects contact your healthcare professional immediately.

Some common side effects include:

• Nausea
• Vomiting
• Weakness
• Fatigue
• Hair loss
• Low blood platelets
• Increased liver enzymes
• Fever
• Anemia (low number of red blood cells)
• Bleeding
• Constipation

• Vinozest 50mg Injection is a prescription-based anticancer drug. It is advised to take this injection after consulting your healthcare expert.
• This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer.​​
  

• Vinozest 50mg Injection is an anticancer medicine with Vinorelbine as an active ingredient which is a alkaloid chemotherapy medication. It acts as a microtubule targeting drug to inhibit mitosis as a result it work by inhibiting the microtubule structure within the cell.
• As microtubule structure promotes cancer cell growth and multiplication and inhibition of these structures by this drug slows the growth and multiplication of cancer cells.​​
  

• Blomqvist, C., Hietanen, P., Teerenhovi, L., & Rissanen, P. (1995). Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study. European Journal of Cancer, 31(13-14), 2406-2408. https://pubmed.ncbi.nlm.nih.gov/8652277/
• Goa, K. L., & Faulds, D. (1994). Vinorelbine: a review of its pharmacological properties and clinical use in cancer chemotherapy. Drugs & aging, 5(3), 200-234.https://pubmed.ncbi.nlm.nih.gov/7803948/
• Johnson, S. A., Harper, P., Hortobagyi, G. N., & Pouillart, P. (1996). Vinorelbine: an overview. Cancer treatment reviews, 22(2), 127-142. https://pubmed.ncbi.nlm.nih.gov/8665565/
• Goa, K. L., & Faulds, D. (1994). Vinorelbine: a review of its pharmacological properties and clinical use in cancer chemotherapy. Drugs & aging, 5(3), 200-234.
• Bonneterre, J., & Penel, N. (2008). Vinorelbine in breast cancer. Expert Opinion on Pharmacotherapy, 9(16), 2901-2910.